人类瘤中的L1CAM/CD171表达及其与瘤表型的关联
Seyma Büyücek1, Magalie Lurati1, Katharina Möller1
1Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Acta oncologica (Stockholm, Sweden)
|December 2, 2025
概括
L1CAM (CD171) 在各种癌症中表达,这表明它是潜在的药物标. 虽然L1CAM表达与侵略性表型无关,但它突出了针对性治疗的特定瘤类型.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫组织化学 免疫组织化学
背景情况:
- L1细胞粘附分子 (L1CAM/CD171) 在癌症进展中起作用.
- 它在正常组织中的有限表达和细胞表面局部化使L1CAM成为癌症治疗的有希望的标.
研究的目的:
- 为了研究L1CAM在广泛的癌症类型中的表达模式.
- 确定特定的瘤实体,其中L1CAM表达可能具有治疗相关性.
主要方法:
- 免疫组织化学在大型组织微阵列上进行.
- 该研究包括来自135个实体的20079个瘤样本和来自76个实体的608个正常组织样本.
主要成果:
- 在135个瘤实体中的74个瘤实体中,在9.1%的可解释瘤样本中检测到L1CAM.
- 在神经瘤,子宫内膜癌,卵巢癌,黑色素瘤和尿道瘤中观察到高的L1CAM阳性.
- L1CAM表达与膀癌的侵入性生长和结直肠癌的不匹配修复缺陷相关.
结论:
- 这些发现确定了特定的癌症类型,具有适合针对性抗L1CAM疗法的L1CAM表达.
- L1CAM表达似乎与具有攻击性的癌细胞表型无关.
相关概念视频
lncRNA - Long Non-coding RNAs
9.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
Non-LTR Retrotransposons
13.1K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.1K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K


